Renaissance Capital logo

AcelRx , Nasdaq: ACRX

Biotech developing a Phase 3 treatment for acute post-operative pain.

Industry: Health Care

First Day Return: -9.0%

Industry: Health Care

Biotech developing a Phase 3 treatment for acute post-operative pain.
more less
IPO Data
IPO File Date 11/12/2010
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 8.0
Deal Size ($mm) $40
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/10/2011
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $40
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Redwood City, CA, United States
Founded 2005
Employees at IPO 19
Website www.acelrx.com

AcelRx (ACRX) Performance